Literature DB >> 8613359

Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis.

J G Fox1, X Li, L Yan, R J Cahill, R Hurley, R Lewis, J C Murphy.   

Abstract

Helicobacter hepaticus causes hepatitis in selected strains of mice and in A/JCr mice is linked to liver cancer. To analyze whether H. hepaticus persists in specified ecological niches, to determine whether biomarkers of infection exist, and to analyze the influence of H. hepaticus on hepatocyte proliferation, a longitudinal study of H. hepaticus-infected A/JCr mice was undertaken. A/JCr mice were serially euthanatized from 3 through 18 months and surveyed by enzyme-linked immunosorbent assay; bacterial culture of liver, colon, and cecum; histology; electron microscopy; hepatocyte proliferation indices determined by using 5-bromo-2'-deoxyuridine; and measurement of the liver enzyme alanine aminotransferase. In infected animals throughout the 18-month study, H. hepaticus was consistently isolated from the lower bowel but only sporadically from the liver. By electron microscopy, H. hepaticus was noted infrequently and only in bile canaliculi. Infected mice, particularly males, showed chronic inflammation; oval cell, Kupffer cell, and Ito cell hyperplasia; hepatocytomegaly; and bile duct proliferation. The inflammatory and necrotizing lesion was progressive and involved the hepatic parenchyma, portal triads, and intralobular venules. Hepatic adenomas were noted only in male mice, whereas 5-bromo-2'-deoxyuridine proliferation indices were markedly increased in both sexes, but especially in males, compared to control A/J mice. Infected mice also developed sustained anti-H. hepaticus serum immunoglobulin G antibody responses and elevated alanine aminotransferase levels. H. hepaticus, which persists in the lower bowels and livers of A/JCr mice, is associated with a chronic proliferative hepatitis, and hepatomas in selected male mice indicate that this novel bacterium may cause an increased risk of hepatic cancer induction in susceptible strains of mice. This murine model should prove useful in dissecting the molecular events operable in the development of neoplasms induced by bacteria belonging to this expanding genera of pathogenic Helicobacter species.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613359      PMCID: PMC173960          DOI: 10.1128/iai.64.5.1548-1558.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; J M Melhorn; P Gorelick; L Yan; J G Fox
Journal:  Lab Anim Sci       Date:  1996-02

2.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.

Authors:  N Figura; P Guglielmetti; A Rossolini; A Barberi; G Cusi; R A Musmanno; M Russi; S Quaranta
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  A small animal model of human Helicobacter pylori active chronic gastritis.

Authors:  A Lee; J G Fox; G Otto; J Murphy
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

5.  Ultrastructural morphogenesis of 4-ipomeanol-induced bronchiolitis and interstitial pneumonia in calves.

Authors:  X Li; W L Castleman
Journal:  Vet Pathol       Date:  1990-05       Impact factor: 2.221

6.  Intracellular vacuolization caused by the urease of Helicobacter pylori.

Authors:  J K Xu; C S Goodwin; M Cooper; J Robinson
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

7.  Helicobacter pylori urease activity is toxic to human gastric epithelial cells.

Authors:  D T Smoot; H L Mobley; G R Chippendale; J F Lewison; J H Resau
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma.

Authors:  J G Fox; P Correa; N S Taylor; D Zavala; E Fontham; F Janney; E Rodriguez; F Hunter; S Diavolitsis
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Monoclonal antibodies for specific immunoperoxidase detection of Campylobacter pylori.

Authors:  R Negrini; L Lisato; L Cavazzini; P Maini; S Gullini; O Basso; G Lanza; M Garofalo; I Nenci
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

View more
  95 in total

1.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

Review 2.  Non-pylori Helicobacter species in humans.

Authors:  J L O'Rourke; M Grehan; A Lee
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

3.  Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient mice.

Authors:  K A Eaton; J S Opp; B M Gray; I L Bergin; V B Young
Journal:  Vet Pathol       Date:  2010-10-06       Impact factor: 2.221

4.  Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus.

Authors:  M A Sipowicz; P Chomarat; B A Diwan; M A Anver; Y C Awasthi; J M Ward; J M Rice; K S Kasprzak; C P Wild; L M Anderson
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

5.  Helicobacter hepaticus hydrogenase mutants are deficient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice.

Authors:  Nalini S Mehta; Stephane Benoit; Jagannatha V Mysore; Renato S Sousa; Robert J Maier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 6.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

7.  Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.

Authors:  Prasant K Jena; Lili Sheng; Hui-Xin Liu; Karen M Kalanetra; Annie Mirsoian; William J Murphy; Samuel W French; Viswanathan V Krishnan; David A Mills; Yu-Jui Yvonne Wan
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

Review 8.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress.

Authors:  Navasona Krishnan; Alan R Doster; Gerald E Duhamel; Donald F Becker
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

10.  Development of a PCR-restriction fragment length polymorphism assay using the nucleotide sequence of the Helicobacter hepaticus urease structural genes ureAB.

Authors:  Z Shen; D B Schauer; H L Mobley; J G Fox
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.